Harper Ellsworth Advertising Named Finalist for 2024 MM+M Awards

Harper Ellsworth Advertising, with client Texas Radiotherapy, is a finalist for the 2024 MM+M Awards in the category of 'Use of Hospital or Healthcare Services Marketing'. The MM+M Awards event recognizes, champions, and celebrates creativity and effectiveness in healthcare marketing and communications. Finalists are invited to attend the awards gala in New York, New York on October 10, 2024. With an MM+M Award, recognition comes from industry peers. More than 90 judges boasting a wide variety of expertise narrowed down the hundreds of entries to a select few. It's this rigorous analysis that has made the MM+M Awards the industry's gold standard. Kathlene Simmons, CEO of Harper Ellsworth, stated, 'We are thrilled that our work for Texas Radiotherapy is selected as a finalist for such a prestigious award. This recognition is the result of incredible teamwork from many talented individuals. We all worked seamlessly together to help deliver the client's goals and make men more aware of prostate cancer.' Melvin Strobbe, Project Creative Director, added, 'The key to our creative output was having such a great client: Texas Radiotherapy. Dr. Matthew and Sara Cavey were excellent on and off camera and helped us hone a strategy, profiling actual patients, that was based on patient truth.'